Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 6.83 M8.82 M9.05 M10.45 M9.68 M 38.01 M Research & development ————— — Operating income 11.23 M17.73 M10.7 M25.89 M19.64 M 73.96 M Non-Operating Income, Total -6.11 M-17.51 M-6.25 M-9.06 M-5.46 M -38.27 M Interest expense, net of interest capitalized 6.42 M6.8 M6.99 M7.14 M6.4 M 27.33 M Non-Operating Income, excl. Interest Expenses -6.26 M-12.15 M-6.62 M-8.1 M-5.93 M -32.8 M Unusual income/expense -6.26 M-12.15 M-6.62 M-8.1 M-5.93 M -32.8 M Pretax income 4.96 M5.58 M4.08 M17.78 M13.71 M 41.16 M Equity in earnings -40 K893 K49 K45 K33 K 1.02 M Taxes 265 K1.38 M1.05 M6.75 M4.02 M 13.2 M Non-controlling/minority interest 174 K817 K888 K1.58 M1.2 M 4.49 M After tax other income/expense ————— — Net income before discontinued operations 4.52 M3.38 M2.15 M9.45 M8.49 M 23.47 M Discontinued operations ————— — Net income 4.52 M3.38 M2.15 M9.45 M8.49 M 23.47 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 4.7 M3.54 M2.35 M10.03 M8.95 M 24.87 M Basic earnings per share (Basic EPS) 0.040.030.020.090.08 0.22 Diluted earnings per share (Diluted EPS) 0.040.030.020.080.08 0.21 Average basic shares outstanding 110.91 M110.99 M109.93 M110.39 M109.52 M — Diluted shares outstanding 119.35 M118.72 M117.8 M118.06 M117.3 M — EBITDA 17.28 M24.66 M17.75 M50.69 M25.91 M 119.02 M EBIT 11.23 M17.73 M10.7 M25.89 M19.64 M 73.96 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 6.06 M6.93 M7.05 M24.81 M6.27 M 45.06 M